Co-Authors
This is a "connection" page, showing publications co-authored by George Gao and Yi Shi.
Connection Strength
0.457
-
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir. Signal Transduct Target Ther. 2021 02 04; 6(1):51.
Score: 0.232
-
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020 09 04; 11(1):4417.
Score: 0.225